ADBiotech Co

ADBiotech Co Debt

The Debt of ADBiotech Co (179530.KQ) as of Oct 20, 2026 is 3.03 B KRW. In the previous year, Debt was 9.05 B KRW — a change of -66.55% (lower).

Debt

3.03 BKRW

YoY

-66.55%

Last updated:

In 2025, ADBiotech Co's total debt was 3.03 B KRW, a -66.55% change from the 9.05 B KRW total debt recorded in the previous year.

The ADBiotech Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
3.52 B KRW
Jan 1, 2019
2.32 B KRW
Jan 1, 2020
5.77 B KRW
Jan 1, 2021
5.81 B KRW
Jan 1, 2022
7.52 B KRW
Jan 1, 2023
7.66 B KRW
Jan 1, 2024
9.05 B KRW
Jan 1, 2025
3.03 B KRW
The ADBiotech Co Debt history
YEARDebtYoY
3.03 BKRW-66.55%
9.05 BKRW+18.19%
7.66 BKRW+1.84%
7.52 BKRW+29.43%
5.81 BKRW+0.60%
5.77 BKRW+148.92%
2.32 BKRW-34.17%
3.52 BKRW-10.40%
3.93 BKRW-34.42%
6.00 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding ADBiotech Co's Debt Structure

ADBiotech Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing ADBiotech Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to ADBiotech Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in ADBiotech Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about ADBiotech Co stock

Debt of ADBiotech Co is 3.03 B KRW in 2025.

Debt of ADBiotech Co changed from 9.05 B KRW to 3.03 B KRW, representing a -66.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — ADBiotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — ADBiotech Co